CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Erepsin

intestinal enzyme mixture

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionOct 15, 2025
Entity authorityQ386404
Source-derived summary

Erepsin is a mixture of enzymes contained in a protein fraction found in the intestinal juices that digest peptones into amino acids. It is produced and secreted by the intestinal glands in the ileum and the pancreas, but it is also found widely in other cells. However, the term is now rarely used in scientific literature as more precise terms are preferred.

History

Erepsin was discovered at the beginning of the twentieth century by German physiologist Otto Cohnheim (1873-1953) who found a substance that breaks down peptones into amino acid in the intestines. He termed this hypothetical protease in his protein extract "erepsin" in 1901, derived from a Greek word meaning "I break down" (έρείπω). His discovery was significant as it overturned the previous "hypothesis of resynthesis" which proposed that proteins get broken down into peptones from which proteins may then be resynthesized, and helped establish the idea of free amino acids instead of peptones being the building blocks of protein.

Erepsin was originally thought to be a single enzyme or a mixture of a few enzymes involved in the terminal stages of the breakdown of peptides to free amino acids in the intestines. However, it became clear later that erepsin is in fact a complex mixture of different peptidases. It was also found not to be unique to intestinal mucosa and is present widely in many other cells and organisms. The term erepsin fell from use in scientific literature in the latter half of the twentieth century as scientists considered its use as a term for a single enzyme or a few enzymes misleading, and more precise terms such as aminopeptidase, carboxypeptidase and dipeptidase are preferred.

Editorial summary

Begin with the source’s own compact description: “Erepsin” is intestinal enzyme mixture. The dossier treats that line as a proposition to test through Erepsin, intestinal and enzyme, not as a finished interpretation.

Editorial reviewA practical starting point whose main value is the path it opens into stronger specialist and primary sources. The current lead gives the account dated anchors—1873, 1953, 1901—that can be checked directly. The selected authority fields contribute no independent date. For this dossier, Erepsin, intestinal and enzyme is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “intestinal enzyme mixture” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Oct 15, 2025. The linked authority identifier is Q386404. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1873, 1953 and 1901.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Erepsin”, its source revision and the description used here.
  2. Expand the search: follow Erepsin primary sources, Erepsin archive and Erepsin research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Erepsin”?
  2. Which institution is responsible for the underlying evidence?
  3. Which cited source is closest to the event, object or claim?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Erepsin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.